RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kane Biotech Stock

Kane Biotech Stocks 2024

Kane Biotech Stocks

127.12 M

Ticker

KNE.V

ISIN

CA4838092084

In 2024, Kane Biotech had 127.12 M outstanding stocks, a 5.32% change from the 120.7 M stocks in the previous year.

The Kane Biotech Stocks history

YEARNUMBER OF STOCKS (undefined CAD)
2023127.12
2022120.7
2021112.6
2020107.55
201982.3
201880.11
201761.28
201637.68
201521.92
201416.65
201315.76
201212.29
201110.98
20107.52
20095.73
20084.85
20073.59
20063.24
20052.88

Kane Biotech shares outstanding

The number of shares was Kane Biotech in 2023 — This indicates how many shares 127.12 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Kane Biotech earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Kane Biotech's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Kane Biotech’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Kane Biotech's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Kane Biotech Aktienanalyse

What does Kane Biotech do?

Kane Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Kane Biotech's Shares Outstanding

Kane Biotech's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Kane Biotech’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Kane Biotech’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Kane Biotech’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Kane Biotech stock

How many stocks are there of Kane Biotech?

The current number of stocks of Kane Biotech is 127.12 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Kane Biotech are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Kane Biotech evolved in recent years?

The number of shares of Kane Biotech has increased by 5.32% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Kane Biotech as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Kane Biotech?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Kane Biotech pay?

Over the past 12 months, Kane Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Kane Biotech is expected to pay a dividend of 0 CAD.

What is the dividend yield of Kane Biotech?

The current dividend yield of Kane Biotech is .

When does Kane Biotech pay dividends?

Kane Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Kane Biotech?

Kane Biotech paid dividends every year for the past 0 years.

What is the dividend of Kane Biotech?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Kane Biotech located?

Kane Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kane Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kane Biotech from 9/29/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Kane Biotech pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Kane Biotech in the year 2023?

In the year 2023, Kane Biotech distributed 0 CAD as dividends.

In which currency does Kane Biotech pay out the dividend?

The dividends of Kane Biotech are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kane Biotech

Our stock analysis for Kane Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kane Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.